Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07680842 · ClinicalTrials.gov registry record · NA
Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
A NA study, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07680842: Recruiting NA study, sponsored by University of California, San Francisco.
NCT07680842 is a NA study that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07680842, a NA study, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this study is to investigate the effects of a non-invasive, low intensity focused ultrasound (LIFU) stimulation on seizure frequency and the epileptogenic network in drug-resistant epilepsy. LIFU uses focused sound waves to modulate deep brain regions and to enable changes in brain network activity. Encephalography (EEG) and behavioral tasks will also be used to study how LIFU affects brain activity.
Primary Outcome
Seizure counts will be obtained from a seizure diary kept by each participant.
Interventions
- DEVICE Target optimization using LIFU
- DEVICE Serial LIFU stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-07-09 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What NCT07680842 shows while recruiting
NCT07680842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Target optimization using LIFU is the first listed.
NCT07680842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07680842 about?
NCT07680842 is a clinical study titled "Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy". The goal of this study is to investigate the effects of a non-invasive, low intensity focused ultrasound (LIFU) stimulation on seizure frequency and the epileptogenic network in drug-resistant epilepsy. LIFU uses focused sound waves to modulate deep brain regions and to enable changes in brain netwo...
What is the current status of trial NCT07680842?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-09. Estimated completion is 2027-06-01.
What interventions are being tested in trial NCT07680842?
The interventions under investigation include: Target optimization using LIFU (DEVICE), Serial LIFU stimulation (DEVICE).
Who is sponsoring clinical trial NCT07680842?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07680842's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI